Prostate Cancer
Genome-wide association study of prostate-specific antigen levels in 392,522 men identifies new loci and improves prediction across ancestry groups.
February 12, 2025
MRI-based risk stratification for clinically significant prostate cancer detection at biopsy: The value of zonal-specific PSA density and PSHS.
February 12, 2025
The Benefit of Short-Term Androgen Deprivation Therapy with Radiotherapy for Intermediate-Risk Prostate Cancer.
February 12, 2025
Radiotherapy quality assurance for the PEACE 1 trial: An individual case review analysis.
February 12, 2025
Development of a deep learning system for predicting biochemical recurrence in prostate cancer.
February 12, 2025
Integrating Prostate Surface Membrane Antigen-PET into Clinical Practice for Prostate Cancer.
February 11, 2025
Integrating radiological and clinical data for clinically significant prostate cancer detection with machine learning techniques.
February 10, 2025
ATAD2 Drives Prostate Cancer Progression to Metastasis.
February 10, 2025
Implementing and Optimizing Universal Germline Genetic Testing for Patients with Prostate Cancer in Clinical Practice Consider.
February 10, 2025
Mitochondrial KMT9 methylates DLAT to control pyruvate dehydrogenase activity and prostate cancer growth.
February 10, 2025
MR-guided Transrectal Focal Laser Ablation for Localized Low- and Intermediate Risk Prostate Cancer: Initial Outcomes Using an Integrated Laser Ablation System.
February 10, 2025
Long-term outcomes of LDR-brachytherapy for localized prostate cancer.
February 10, 2025